Speaker - Anne Hanham

 Anne  Hanham  Thumbnail


Anne Hanham is the managing director at Burrill & Company, and is currently on the Board of Directors of Adlyfe, Elbion, Endocyte, Logical Therapeutics, Neosil, and Veritas Medicine.

She was a co-founder and vice president of clinical and regulatory affairs at InterMune Pharmaceuticals, and prior to that, she served as the senior director for oncology product development at Otsuka Pharmaceuticals as well as medical director for Celtrix Pharmaceuticals. She also worked for Becton Dickinson in both regulatory and clinical affairs for the monoclonal antibody program, and as a regulatory toxicologist with the health protection branch of Health and Welfare Canada.

Hanham holds a Ph.D. from the University of British Columbia, a master's degree from Simon Fraser University, and a bachelor's degree from the University of Toronto. She was Board Certified in toxicology in 1986.

1 Program

The Promise of Personalized Health Management

03.30.10 | 01:17:01 min | 1 comment